ABSTRACT NUMBER: ESOC2026YS88 CONTRIBUTION OF GENETIC FACTORS TO THE DEVELOPMENT OF CEREBRAL VENOUS THROMBOSIS AND THE BIOTRANSFORMATION SYSTEM FOR THE SELECTION OF INDIVIDUAL THERAPY
Inna Kustovinova, Nataliia Ermolenko · 2026
Read ABSTRACT NUMBER: ESOC2026YS88 CONTRIBUTION OF GENETIC FACTORS TO THE DEVELOPMENT OF CEREBRAL VENOUS THROMBOSIS AND THE BIOTRANSFORMATION SYSTEM FOR THE SELECTION OF INDIVIDUAL THERAPY by Inna Kustovinova, Nataliia Ermolenko (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145413.txt.
Description
Inna Kustovinova and Nataliia Ermolenko present a conference abstract on genetic factors in cerebral venous thrombosis, a clot in the brain's veins. The abstract notes that this condition can look like ordinary stroke but needs different care. Blood-thinning treatment is essential once the clot is confirmed, yet it carries a real risk of bleeding.
Their study, at a hospital in Voronezh, enrolled 30 patients with suspected vein clots or unclear stroke. Scans confirmed cases, and gene tests covered clotting factors and drug-processing genes. The aim was twofold: find genetic drivers of the disease, and use drug-gene profiles to tailor each patient's therapy. Gene results were meant to guide each patient's drug and dose choice.
Catalog record
| CREATOR | Inna Kustovinova, Nataliia Ermolenko |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |